Literature DB >> 11548124

Long-time expression of DNA repair enzymes MGMT and APE in human peripheral blood mononuclear cells.

K Janssen1, U Eichhorn-Grombacher, K Schlink, S Nitzsche, F Oesch, B Kaina.   

Abstract

The DNA repair enzymes O6-methylguanine-DNA methyltransferase (MGMT) and apurinic/apyrimidinic endonuclease (APE, also known as Ref-1) play an important role in cellular defense against the mutagenic and carcinogenic effects of DNA-damaging agents. Cells with low enzyme activity are more sensitive to induced DNA damage and may confer a higher carcinogenic risk to the individuals in question. To study the level of variability of MGMT and APE expression in human, we analyzed in a long-time study MGMT and APE expression in peripheral blood mononuclear cells (PBMC) from healthy individuals. The data revealed high inter- and intraindividual variability of MGMT but not of APE. For MGMT, the interindividual levels ranged from 27 to 204 fmol/10(6) cells (7.6-fold, 40 healthy individuals). The intraindividual variation was determined by measuring MGMT repeatedly over 42 days, and was found to vary from 1.4-fold to 3.5-fold. Averaging over the measurement period, some individuals displayed low MGMT activity compared to others. In contrast, APE expression showed only a 2.9-fold difference between individuals and a 1.2 to 2.3-fold intra-individual long-time variation, and thus was less variable than MGMT. MGMT and APE expression were not correlated. Overall the results showed variable MGMT and rather constant APE levels in PBMC of healthy individuals measured over a long period.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11548124     DOI: 10.1007/s002040100226

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  3 in total

Review 1.  Targeting O⁶-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy.

Authors:  Bernd Kaina; Geoffrey P Margison; Markus Christmann
Journal:  Cell Mol Life Sci       Date:  2010-08-18       Impact factor: 9.261

2.  Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.

Authors:  L M FitzGerald; S Zhao; A Leonardson; M S Geybels; S Kolb; D W Lin; J L Wright; R Eeles; Z Kote-Jarai; K Govindasami; G G Giles; M C Southey; J Schleutker; T L Tammela; C Sipeky; K L Penney; M J Stampfer; H Gronberg; F Wiklund; P Stattin; J Hugosson; D M Karyadi; E A Ostrander; Z Feng; J L Stanford
Journal:  Prostate Cancer Prostatic Dis       Date:  2018-01-03       Impact factor: 5.554

3.  Alkylation and Carbamylation Effects of Lomustine and Its Major Metabolites and MGMT Expression in Canine Cells.

Authors:  Thushara Chakkath; Sidonie Lavergne; Timothy M Fan; David Bunick; Levent Dirikolu
Journal:  Vet Sci       Date:  2015-04-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.